Grants and Contributions:
Title:
ARP - Development of a Risk Prediction Model for Early Breast Cancer Detection.
Agreement Number:
1027445
Agreement Value:
$74,900.00
Agreement Date:
Feb 24, 2025 - Jul 31, 2025
Description:
This feasibility project is aiming to develop a non-invasive blood test that can detect breast cancer at a very early stage, when treatment is most effective.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Quebec, Quebec, CA G1P 4P5
Reference Number:
172-2024-2025-Q4-1027445
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
796635662
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 27 days.
Amendment Date
Jun 26, 2025
Recipient's Operating Name:
Biomark Diagnostic Solutions inc.
Recipient's Legal Name:
Solutions de Diagnostic Biomark inc.
Federal Riding Name:
Québec
Federal Riding Number:
24059
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
621510
Amendments: